chronic bronchitis, asthma, and cystic fibrosis are associated with an impairment of mucociliary clearance,2-4 and exposure to various noxious agents such as cigarette smoke, ammonia, formaldehyde, and sulphur dioxide (SO2) can result in inhibition of ciliary function or ciliostasis.5 6 Azelastine, 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1 H-azepin-4-yl)-1-(2H)-phthalazione hydrochloride, is an orally effective and long lasting antiallergic drug that prevents bronchospasm by inhibiting histamine release from mast cells7 and leukotriene synthesis in the lung.8 In addition, this drug possesses anti-inflammatory actions including suppression of superoxide generation by leukocytes,9 prostaglandin release from macrophages,'0 and microvascular leakage."
The purpose of the present study was (a) to characterise the SO2 induced inhibition of airway ciliary motility; (b) to determine whether azelastine can protect against airway mucociliary dysfumction; and (c) if so, to investigate its mechanism of action. We therefore studied ciliary motility of human airway epithelium in vitro by a photoelectric method.
Methods

TISSUE PREPARATION
Fibreoptic bronchoscopy including transbronchial lung biopsy was carried out on 24 patients with a peripheral lung cancer. None had a history of respiratory tract infection for at least one month and any medication was stopped 14 days before the bronchoscopy. After topical anaesthesia of the upper airway with 4% lignocaine, a fibreoptic bronchoscope (Type 1T20; Olympus, Tokyo, Japan) was inserted transorally through an endotracheal tube. A standard bronchial brush (BC-9C; Olympus) was passed through the biopsy channel and epithelial cells were scraped at three different levels: the carina of the right upper lobe; the orifice of the middle lobe; and in a segment of the right lower lobe. Collection of samples was restricted to areas free of obvious mucosal invasion by carcinoma or acute inflammation, swelling, pus, or reddening. The cells were extracted from the brush by brisk agitation in a petri dish containing Krebs-Henseleit solution of the following composition (in mmol/l): NaCl, 118; Effect of azelastine on sulphur dioxide induced impairment of ciliary motility in airvay epithelium suspension was then transferred to a Rose chamber'2 for the measurement of ciliary beat frequency (CBF) within 30 minutes.
MEASUREMENT OF CBF
To measure CBF of the airway epithelium a microscope (Optiphoto-XF; Nikon, Tokyo) equipped with a trinocular body, a phase contrast condenser, and an on base type of halogen illuminator were used.'3 14 The photometer (NFX-II; Hamamatsu Photonics, Hamamatsu, Japan) with an inbuilt periplanatic eyepiece, a limiting aperture, and a lateral focusing telescope was attached to the head of the microscope. The Rose chamber containing epithelial cells was set on a microscope stage maintained at 37°C by an air stream stage incubator (E5B2; Omron, Tokyo) and perfused with warmed Krebs-Henseleit solution aerated with 95% 02 and 5% CO2 at a constant pressure of 20 cm H20.
Light from the illuminator passed through the preparation in varying intensities because of the beating action of the cilia; this was viewed directly at a magnification of x 400. Variations of light intensity were detected by the photometer and transduced to voltage impulses. These electrical signals were amplified, displayed on the oscilloscope screen (LBO-522; Leader, Tokyo), and recorded by a pen recorder (VP6213; Panasonic, Tokyo). Throughout the experiment, the same group of cilia in each preparation was studied-that is, the relative position of the diaphragm of the photometer and the selected epithelial border were kept constant. The choice of the ciliated area was randomised by using an eyepiece graticule and selecting the group of cilia which lay closest to the crosspiece of the graticule on the equatorial line. The longitudinal axis of the field of the photometer was viewed perpendicular to the cell border and the measurements of CBF were averaged from clumps of two or more cells with borders free of debris. The mean intracell coefficient of variation of CBF, defined as the ratio of the standard deviation to the mean value as a percentage, was less than 5%. There were no significant differences in CBF among epithelial cells obtained from three different levels of the airway.
In The preparation was allowed to stabilise for 30 minutes before the measurement of CBF. After determination of baseline CBF, azelastine (Eizai Company, Tokyo) in a concentration of 10-4 mol/l was added to the perfusate and CBF was continuously recorded for the next 20 minutes. For time controls, measurements were obtained when only KrebsHenseleit solution was used for perfusion. To generate the CBF dose-response curves, azelastine was cumulatively added in half molar increments from 10-7 to 10-3 mol/l, and the response to a given concentration was allowed to reach a plateau before proceeding to the next higher concentration.
To test any protective action of azelastine on ciliary dysfunction, we examined the effect of pretreatment of the cells with azelastine on the SO2 induced decrease in CBF. The preparation was incubated with 10-6 mol/l azelastine for 20 minutes. When the CBF response reached a plateau, Krebs-Henseleit solution with a mixture of 95% 02, 5% CO2 and 3 ppm SO2 bubbling through it perfused the cells and azelastine mixture for 20 minutes. In this series of experiments, cells were preincubated with various concentrations of azelastine at 10-7 to 10-I mol/l and the responses of CBF to SO2 were determined in order to assess a dose-response relationship.
MEASUREMENT OF CYCLIC AMP
After 20 minutes exposure of epithelial cells to azelastine alone, SO2 alone, or S02 plus azelastine, preparations were quickly removed from the chambers and sonicated with a bath type sonicator (PT-101; Sino Company, Tokyo) in ice cold 10% trichloroacetic acid. After the extraction of trichloroacetic acid with ether, the residue was dissolved in acetate buffer. The cyclic AMP levels were measured in duplicate by [3H] cyclic AMP (New England Nuclear, Boston, Massachusetts, USA),'6 corrected for ether extraction of 86% recovery, and normalised for protein content of the cells by the Lowry method'7 with bovine serum albumin as a standard.
STATISTICAL ANALYSES
The effects of azelastine and SO2 on CBF were compared with the appropriate time controls (Krebs-Henseleit solution alone) using Friedman's two way analysis of variance. Comparisons between the effects of SO2 with or without azelastine were made with the Kruskal-Wallis one way analysis of variance test. A different donor of ciliated cells was used in each experiment; n refers to the number of patients from which samples were obtained, and a p value of <0 05 was considered significant.
Results
There was no significant difference in baseline CBF between the cells treated with azelastine and the Krebs-Henseleit solution time controls. The CBF did not change significantly during a 20 minute observation period in the control experiment, whereas addition of azelastine (10-4 mol/l) rapidly increased the mean (SE) CBF from 17-2 (0-7) Hz to a peak value of (1-2) Hz within five minutes, being significantly faster than the control (p < 0-05, n = 1 1), and remained faster thereafter (fig 1) . The stimulatory effect of Control dependent fashion. The decrease in CBF was 24-4 (3 9)%, 17-6 (2-2)%, 9 1 (2 8)%, and 6-6 (1-0)% for concentrations of 3 x 10-7, 10-6, 3 x 10,6, and 10-mol/l azelastme, 7 -6, maximal increase from the baseline decreased intracellular cyclic AMP levels i the concentration required to pro-from 38&2 (4-3) to 10<1 (2-4) pmol/mg proalf maximal effect being 27-0 (4 2)% tein (p < 0-01, n = 12). Azelastine pretreat-), n = 9) and 9-2 x 10-6 mol/l, ment prevented this effect in a dose ely (fig 2) . This was accompanied by dependent manner so that the reduction of nding increases in intracellular cyclic cyclic AMP levels was completely reversed at rels (fig 3) where the threshold con-concentrations of 3 x 10-6 and 10-1 mol/l n of azelastine (3 x 10-6 mol/1) was (fig 6) . identical to that for ciliary stimulation.
The addition of 3 ppm SO2 to the perfusate caused a rapid reduction of ciliary motility, with the CBF values significantly slower than the control experiments at 2-5-20 minutes after the initiation of SO2 exposure (p < 0-05, n = 10), an effect that was significantly inhibited by pretreatment of cells with 10-6 mol/I azelastine (fig 4) . The maximal decrease in CBF from the baseline value induced by SO2 was 59-2 (5-0)%, and azelastine protected against this inhibition in a dose Effect of azelastine on sulphur dioxide induced impairment of ciliary motility in airway epithelium Mucociliary clearance in the re tract has been known to be impairec ous airway diseases such as chronic tis, asthma, and cystic fibrosis,2-4 an inhalation of several noxious agents.56 ttt Dalhamn5 reported that SO2 inhibited ciliary ttt activity of rat tracheal epithelial cells but its mechanism of action was unknown. We found in human bronchial epithelium that exposure to SO2 likewise decreased CBF and that this effect was accompanied by a decrease in intracellular cyclic AMP content. The SO2 induced interference with ciliary activity may therefore be at least in part due to the impairment of cyclic AMP production. It remains to be determined, however, I 5i-51 whether SO2 acts directly on the cyclic AMP ] (mol/l) dependent pathway in the epithelium or indirectly by stimulating cilioinhibitory mediators such as adenosine'4 and oxygen radicals.25 Recent evidence suggests that the agent capable of elevating cyclic AMP in airway epithelium can prevent lung injury.26 In this study pretreatment of epithelial cells with azedlates cil-lastine at concentrations insufficient to pithelium increase intracellular cyclic AMP levels by a bySO2, itself (3 x 10-7 moll, 10-6 moll) reversed of intra-the SO2 induced reduction of CBF and cyclic AMP levels. We therefore speculate that this iotility in reversal may be produced by the inhibition of endoge-cyclic AMP loss. iAAMP,13
In conclusion, the present studies indicate e present that the antiallergic drug azelastine not only f airway enhances the beating action of human hion, the bronchial cilia but also protects against the e a half impairment of ciliary motility, and suggest /1) being that this drug could be of value in patients o inhibit with mucociliary dysfunction. The lung has no parenchyma
In case this proposition seems too iconoclastic, I will restate it as follows: within the lung there is no tissue that can usefully be identified and named "parenchyma." I have urged for many years that the use of this word in relation to the lung is inappropriate and should be avoided. Avoidance is not difficult. George Simom managed to write an excellent textbook on lung radiology (Principles of chest x-ray diagnosis, 3rd edn. Butterworth, London, 1971) without once using the phrase "lung parenchyma". Fifteen years ago I confirmed in a formal study (Br J Dis Chest 1978;72:1-12) that the meanings attached to this phrase by physicians and radiologists on both sides of the Atlantic are so varied that it is virtually meaningless. In many instances the word "parenchyma" can be omitted without altering the apparently intended meaning; in others it is necessary to ascertain the sense in which this word is being used. This sense is usually discordant with accepted usages of "parenchyma" in relation to other organs. How did this verbal confusion arise? In relation to secreting glands or the liver, "parenchyma" refers to tissues composed of cells having functions specific to the organ concerned, as opposed to supporting and vascular tissues; this usage is unequivocal and, I believe, generally accepted. In the lung I suppose the cells that might be considered to be most organ specific are the type II pneumocytes, but it would be absurd to call them the lung parenchyma! The function of the lung depends not upon any one type of cell, but upon the structural and functional interaction of elements of its vasculature and airways to bring about orderly gas exchange in the alveoli. In general it seems that what most people mean when they speak of the lung parenchyma is its peripheral gas exchanging part. There is a fairly well defined demarcation at the ends of the terminal bronchioles between the part in which movement of gas is by diffusion both within airspaces and across alveolar membranes, and airways in which it is by ventilatory to and fro movement. It is now agreed that the part of the lung associated with a terminal bronchiole should be called an acinus; thus I think that what is usually meant by the "lung parenchyma" is the pulmonary acini. If you hear or read these words, consider first whether the word "parenchyma" contributes anything; it can often be eliminated without loss of meaning. It may be evident from context that the intended reference is to the pulmonary acini, as opposed to the airways. If you do not think that anyone using these words has this meaning in mind, ask what he or she really means.
I recommend that this weasel word be eliminated from discourse concerning the lung.
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